Patents by Inventor Andrea Sedivy

Andrea Sedivy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATION
    Publication number: 20170153256
    Abstract: The present invention relates to a platelet subpopulation with high binding capacity to recombinant activated factor VII (rFVIIa), and its use for the treatment of bleeding disorders and for determining whether a subject is a candidate for treatment with rFVIIa.
    Type: Application
    Filed: December 7, 2016
    Publication date: June 1, 2017
    Applicants: BAXALTA INCORPORATED, BAXALTA GMBH
    Inventors: Ernst Böhm, Michael Dockal, Andrea Sedivy
  • Methods for treating bleeding disorders using a platelet subpopulation
    Patent number: 9545436
    Abstract: The present invention relates to a platelet subpopulation with high binding capacity to recombinant activated factor VII (rFVIIa), and its use for the treatment of bleeding disorders and for determining whether a subject is a candidate for treatment with rFVIIa.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: January 17, 2017
    Assignees: BAXALTA GMBH, BAXALTA INCORPORATED
    Inventors: Ernst Böhm, Michael Dockal, Andrea Sedivy
  • METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATION
    Publication number: 20160114010
    Abstract: The present invention relates to a platelet subpopulation with high binding capacity to recombinant activated factor VII (rFVIIa), and its use for the treatment of bleeding disorders and for determining whether a subject is a candidate for treatment with rFVIIa.
    Type: Application
    Filed: March 14, 2014
    Publication date: April 28, 2016
    Inventors: Ernst Böhm, Michael Dockal, Andrea Sedivy
  • METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATION
    Publication number: 20140294794
    Abstract: The present invention relates to a platelet subpopulation with high binding capacity to recombinant activated factor VII (rFVIIa), and its use for the treatment of bleeding disorders and for determining whether a subject is a candidate for treatment with rFVIIa.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 2, 2014
    Applicants: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.
    Inventors: Ernst Böhm, Michael Dockal, Andrea Sedivy